Physician profile
Collin E Ball
NPI 1619166378
$6,043.48
in general payments reported to CMS, 2019-2025
28 companies · $817 in 2025
The $817 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,880 · 2020: $502 · 2021: $703 · 2022: $547 · 2023: $754 · 2024: $840 · 2025: $817.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,410.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,762.77 | 2019-2025 | Oasis, Grafix Pl, Grafix |
| Paratek Pharmaceuticals, INC. | $648.00 | 2022-2025 | Nuzyra |
| Averitas Pharma INC. | $538.21 | 2023-2025 | Qutenza |
| Osiris Therapeutics INC. | $340.57 | 2019 | |
| Acumed LLC | $340.17 | 2024-2025 | Acumed, Acumed, Osteomed |
| Integra Lifesciences Corporation | $292.93 | 2019-2020 | |
| Abbott Laboratories | $249.61 | 2019 | |
| Abbvie INC. | $206.93 | 2022-2024 | Dalvance |
| Stryker Corporation | $102.52 | 2019-2022 | |
| Vertex Pharmaceuticals Incorporated | $91.85 | 2025 | |
| Zimmer Biomet Holdings, INC. | $70.81 | 2021 | |
| Melinta Therapeutics, LLC | $46.66 | 2021-2022 | |
| Paragon 28, INC. | $41.25 | 2020 | |
| Linvatec Corporation | $38.55 | 2025 | Biobrace 23mm, Allograft Tissue, Quantum |
| Treace Medical Concepts, INC. | $33.65 | 2022-2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $29.38 | 2020-2024 | Exogen Ultrasound Bone Healing System |
| Pacira Therapeutics, INC. | $24.75 | 2019 | |
| Orthofix Medical, INC. | $23.32 | 2022 | |
| Sanara Medtech INC. | $18.94 | 2025 | Celleraterx |
| Kerecis Limited | $18.63 | 2021 | |
| My01 INC. | $18.31 | 2023 | My01 Continuous Compartmental Pressure Monitor |
| Hartmann USA, INC. | $16.33 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $16.17 | 2025 | Exparel |
| Davol INC. | $15.81 | 2024 | Arista Ah Flexitip |
| Solventum Corporation | $15.77 | 2025 | Activ.A.C. |
| Wright Medical Technology, INC. | $15.37 | 2019 | |
| Avanos Medical | $13.27 | 2022 | |
| Organogenesis INC. | $12.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Collin Ball listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.